α-Santalol
Based on 1 Customer Validation
α-Santalol (cis-α-Santalol), a naturally occurring sesquiterpene, is an orally active anticancer agent and apoptosis inducer. α-Santalol activates caspase-3 to drive apoptotic processes. >α-Santalol induces apoptosis, decreases cell viability, and causes PARP cleavage in human prostate cancer cells. α-santalol inhibits Akt/Survivin pathway to induce cell death. α-Santalol can be used for the research of prostate cancer and diabetes mellitus.
For research use only. We do not sell to patients.
- Purity : 97.62%
- CAS No.: 115-71-9
- Formula: C15H24O
- Molecular Weight:220.35
-
Storage:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Caspase 3 |
In Vitro
α-Santalol (25-75 μM; 24-48 h) decreases viability of androgen-independent PC-3 and androgen-dependent LNCaP human prostate cancer cells in a concentration- and time-dependent manner with an IC50 < 50 μM, while normal human prostate epithelial PrEC cells are relatively resistant to its growth-suppressive effects[1].
α-Santalol (25-50 μM; 24 h) induces apoptotic DNA fragmentation in human prostate cancer PC-3 and LNCaP cells, with LNCaP cells showing greater sensitivity to this effect than PC-3 cells[1].
α-Santalol (50 μM; 24 h) induces morphological features of apoptosis, including condensed and fragmented nuclear DNA, in human prostate cancer PC-3 and LNCaP cells[1].
α-Santalol (50 μM; 24 h) activates caspase-3 in human prostate cancer PC-3 and LNCaP cells, with a more robust response observed in LNCaP cells[1].
α-Santalol (25-50 μM; 24-48 h) induces cleavage of PARP, a downstream substrate of active caspase-3, in human prostate cancer LNCaP cells[1].
α-santalol (20, 40 μM) resulted in the down regulation of survivin and p-AKT (s-473) expression and statistically significant reduction in total survivin levels in prostate cancer cells[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:PC-3 cells, LNCaP cells, PrEC cells
-
Concentration:25 μM, 50 μM, 75 μM
-
Incubation Time:24 h, 48 h
-
Result:Decreased PC-3 cell viability by ~75% after 24-h treatment with 50 μM.
Showed greater growth inhibition sensitivity in LNCaP cells than in PC-3 cells at 48 h.
Reduced PrEC cell viability by ~44% with 75 μM for 24 h, with minimal effects at 25 and 50 μM.
Achieved an IC50 < 50 μM in prostate cancer cells.
-
Cell Line:PC-3 cells, LNCaP cells
-
Concentration:25 μM, 50 μM
-
Incubation Time:24 h
-
Result:Increased cytoplasmic histone-associated DNA fragmentation statistically significantly in both PC-3 and LNCaP cells after 24-h treatment with 50 μM, with an enrichment factor of ~3 in PC-3 cells and ~6 in LNCaP cells.
-
Cell Line:PC-3 cells, LNCaP cells
-
Concentration:50 μM
-
Incubation Time:24 h
-
Result:Increased the percentage of apoptotic cells with condensed/fragmented DNA statistically significantly after 24-h treatment, which were rarely observed in control cultures.
-
Cell Line:LNCaP cells
-
Concentration:25 μM, 50 μM
-
Incubation Time:24-48 h
-
Result:Induced strong expression of cleaved 89 kDa PARP in LNCaP cell lysates.
Increased expression of cleaved 89 kDa PARP at 48 h compared to 24 h.
In Vivo
α-Santalol (12.5-200 mg/kg; 100-200 μg/10 μL; i.p.; p.o.; i.c.v.; single dose) dose-dependently induces central nervous system depressant effects in male ddY mice, including up to 95% reduction in spontaneous locomotor activity at 50 mg/kg i.p., 95% inhibition of acetic acid-induced writhing at 50 mg/kg i.p., and significant increases in hexobarbital-induced sleeping time, hypothermia, and brain HVA/5-HIAA levels at higher doses[2].
α-Santalol (100 mg/kg BW; i.p.) reduces blood glucose by 61% and modulates associated physiological and biochemical parameters to normoglycemic levels in Alloxan (HY-W017227)-induced diabetic male Swiss albino mice[3].
α-Santalol (100 mg/kg BW; i.p.) increases body weight by 27.75% and modulates key oxidative stress and liver function parameters in d-galactose-induced oxidative stress male Swiss albino mice[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ddY mice (male, 23-30 g, 8 per group)[2]
-
Dosage:12.5-50 mg/kg (i.p.); 25-200 mg/kg (p.o.); 100-200 μg/10 μl (i.c.v.)
-
Administration:i.p.; p.o.; i.c.v.; single dose
-
Result:Increased hexobarbital-induced sleeping time .
Reduced acetic acid-induced writhing number.
Reduced Methamphetamine-induced locomotor activity across all intervals.
Increased brain homovanillic acid (HVA) levels to 171% of control.
Produced no significant effect on Reserpine-induced hypothermia.
Produced no significant anticonvulsant effects in chemically-induced or electroshock-induced seizure models (50 mg/kg i.p. and 200 mg/kg p.o.).
-
Animal Model:Swiss albino (male, adult 4 months old, 20-30 g, alloxan-induced diabetic)[3]
-
Dosage:100 mg/kg BW
-
Administration:i.p.
-
Result:Increased body weight by 8.1%.
Reduced water consumption by 89%.
Reduced serum bilirubin by 42.9%.
Reduced serum malondialdehyde (MDA) by 46.1%.
Reduced liver weight by 36.3%.
Increased liver glycogen by 87.4%.
Increased total liver protein by 23.5%.
Reduced blood glucose levels by 61% over 8 days, returning blood glucose to normoglycemic levels (93 ± 9 mg/dl on Day 8).
Chemical Information
-
CAS No. 115-71-9
-
Appearance Liquid (Density: 0.977 g/cm3)
-
Molecular Weight 220.35
-
Formula C15H24O
-
Color Colorless to light yellow
-
SMILES
CC12C(C3)[C@@H]1CC3[C@](C)2CC/C=C(C)\CO
-
Synonyms
cis-α-Santalol
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Bommareddy A, et al. α-Santalol, a derivative of sandalwood oil, induces apoptosis in human prostate cancer cells by causing caspase-3 activation. Phytomedicine. 2012;19(8-9):804-811. [Content Brief]
[2]. Okugawa H, et al. Effect of α-santalol and β-santalol from sandalwood on the central nervous system in mice. Phytomedicine. 1995;2(2):119-126. [Content Brief]
[3]. Misra BB, et al. Evaluation of in vivo anti-hyperglycemic and antioxidant potentials of α-santalol and sandalwood oil. Phytomedicine. 2013;20(5):409-416. [Content Brief]
[4]. Bommareddy A, McGlynn D, Lewis M, Lockus L, Seward J, Hong KL, VanWert AL, Dwivedi C. Akt/survivin pathway inhibition enhances the apoptotic cell death-induced by alpha-santalol in human prostate cancer cells. Fitoterapia. 2020 Jun;143:104552. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- α-Santalol
- 115-71-9
- cis-α-Santalol
- Akt
- Survivin
- Apoptosis
- Caspase
- PARP
- caspase-3
- alloxan-induced diabetic male Swiss albino mice
- mouse brain
- normal human prostate epithelial PrEC cells
- d-galactose-mediated oxidative stress-induced male Swiss albino mice
- human prostate cancer PC-3 cells
- human prostate cancer cells
- human prostate cancer LNCaP cells
- skin cancers
- Inhibitor
- inhibitor
- inhibit